Abstract
Hybrid PET/MR imaging is in early development for treatment planning. This article briefly reviews research and clinical applications of PET/MR imaging in radiation oncology. With improvements in workflow, more specific tracers, and fast and robust acquisition protocols, PET/MR imaging will play an increasingly important role in better target delineation for treatment planning and have clear advantages in the evaluation of tumor response and in a better understanding of tumor heterogeneity. With advances in treatment delivery and the potential of integrating PET/MR imaging with research on radiomics for radiation oncology, quantitative and physiologic information could lead to more precise and personalized RT.
Original language | English |
---|---|
Pages (from-to) | 377-430 |
Number of pages | 54 |
Journal | Magnetic Resonance Imaging Clinics of North America |
Volume | 25 |
Issue number | 2 |
DOIs | |
State | Published - May 1 2017 |
Keywords
- Hybrid PET/MR imaging
- MRI-based treatment planning
- Normal tissue toxicity
- PET tracers
- Radiation therapy
- Tumor heterogeneity
- Tumor response